INCATE
Basel, Basel-Stadtincate.net
Overview
A not-for-profit partnership that serves as an incubator for early-stage innovators and start-ups fighting antimicrobial resistance (AMR). It brings together academia, industry, entrepreneurs, and investors to provide support through expert advice, community building, and non-dilutive funding to accelerate the development of new therapies and diagnostics.
Portfolio Companies
7
Website
incate.netInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| i-Seq Biotechnology | Jun 2026 | Grant | Co-investor |
| Brigid Bio Ltd | Sep 2025 | Pre Seed | Co-investor |
| mycoBiologics Ltd | Feb 2025 | Grant | Lead |
| Arvalus Therapeutics | Dec 2024 | Grant | Lead |
| Invitris | May 2023 | Grant | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
